Kosei Pharma UK Ltd – Trademark Portfolio
Entity Type: 99
Kosei Pharma UK Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 8 Nice Classification classes. The owner is based in Slough.
Slough Trading Estate
956 Buckingham Avenue
Slough SL14NL , GB
Showing of trademarks Trademarks
Trademark Classifications
Kosei Pharma UK Ltd's trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Kosei Pharma UK Ltd have?
Kosei Pharma UK Ltd has 2 U.S. trademarks filed with the USPTO.
What trademark classes does Kosei Pharma UK Ltd file in?
Kosei Pharma UK Ltd files trademarks across 8 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What is Kosei Pharma UK Ltd's trademark registration success rate?
Kosei Pharma UK Ltd has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.